Crown Holdings, Inc. filings document the regulatory record of a Pennsylvania packaging company with common stock listed on the New York Stock Exchange under CCK and long-dated debentures listed under CCK96. Form 8-K reports cover earnings releases, material agreements, executive appointments, director elections, and other corporate events tied to the company’s packaging operations and capital structure.
The company’s proxy materials disclose annual meeting matters, director elections, board governance, and compensation topics. Debt-related filings include credit agreement disclosures involving Crown subsidiaries and securities-listing actions, including Form 25 records for removed debenture classes.
Crown Holdings director Marsha C. Williams reported an acquisition of 351 shares of Crown Holdings common stock on 2026-07-29. The transaction is coded as a grant, award, or other acquisition at a price of $117.69 per share, bringing her directly held position to 8,142 shares of common stock.
Crown Holdings director Caesar F. Sweitzer reported an equity award of 351 shares of common stock on 2026-07-29 at a reported price of $117.69 per share. The action is categorized as a grant/award acquisition and raises his direct holdings to 25,228 shares.
CROWN HOLDINGS, INC. director Angela M. Snyder received a grant of 351 shares of common stock on July 29, 2026, classified as a “Grant, award, or other acquisition.” For reporting purposes, the shares are valued at $117.69 per share, bringing her direct holdings to 7,156 shares.
CROWN HOLDINGS, INC. director Stephen J. Hagge reported a grant of 351 shares of common stock on July 29, 2026, described as a grant, award, or other acquisition at $117.69 per share. Following this award, he directly holds 11,652 Crown Holdings shares.
Owens B Craig reported acquisition or exercise transactions in this Form 4 filing.
Crown Holdings, Inc. director B Craig Owens reported a grant of 351 shares of common stock at $117.69 per share on July 29, 2026. After this award, he directly holds 12,073 shares and also reports 2,000 shares held indirectly through The B Craig Owens Rev Trust.
Funk Andrea J. reported acquisition or exercise transactions in this Form 4 filing.
CROWN HOLDINGS, INC. director Andrea J. Funk reported a grant of 351 shares of common stock on July 29, 2026, valued at $117.69 per share. After this compensation-related award, she directly holds 17,878 common shares. The report indicates this transaction was not made under a Rule 10b5-1 trading plan.
CROWN HOLDINGS, INC. director Richard H. Fearon reported a grant or award acquisition of 351 shares of Common stock on 2026-07-29 at $117.69 per share. After this award, he holds 12,829 shares directly and 16 shares indirectly through the Fearon Family Trust.
DOSS MICHAEL P reported acquisition or exercise transactions in this Form 4 filing.
CROWN HOLDINGS, INC. director Michael P. Doss received a grant of 351.0000 shares of Deferred Stock on July 29, 2026, valued at $117.6900 per share. Each deferred share is economically equivalent to one common share and becomes payable in cash after he ceases to be a Director. Following this award, he holds 770.0000 Deferred Stock shares directly.
Crown Holdings reported stronger results for the quarter ended June 30, 2026. Net sales were $3,668 million, up from $3,149 million a year earlier, driven mainly by $395 million of higher material cost pass-throughs, 5% higher beverage can volumes and favorable currency. Net income attributable to Crown rose to $245 million from $181 million, with diluted EPS increasing to $2.23 from $1.56.
Americas Beverage sales grew but segment income eased as weaker Brazil volumes offset higher North American demand. European Beverage and Asia Pacific delivered higher volumes and segment income, while Transit Packaging saw modest sales growth but lower income amid inflationary pressure. Tinplate and equipment businesses in “Other” improved profitability.
For the first half, operating cash flow increased to $659 million, supporting $203 million of capital expenditures and $517 million of share repurchases under a $2,000 authorization (about $800 remained). Total assets were $14,556 million, with long-term debt (excluding current maturities) of $5,499 million and a total net leverage ratio of 2.42x, within covenant limits. The company also carries a $172 million accrual for asbestos-related claims and faces ongoing environmental, competition-law and Brazilian tax matters.
Gerard Gifford has indicated an intention to sell up to 7,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with a stated value of 843,761.10, in a transaction dated July 28, 2026 on the NYSE.
The disclosure also lists recent sales of common stock over the prior three months, including 5,000 shares for 596,600.50 on July 27, 2026; 7,012 shares for 824,554.45 on July 22, 2026; 2,800 shares for 339,038.00 on July 21, 2026; 100 shares for 11,198.50 on July 2, 2026; and 77 shares for 8,411.87 on June 29, 2026, all reported as common stock transactions.